Focus Partners Advisor Solutions LLC has significantly increased its investment in National Health Investors, Inc. (NYSE:NHI) during the second quarter of 2023. The firm disclosed in a recent filing with the Securities and Exchange Commission (SEC) that it purchased 4,537 shares of the real estate investment trust, amounting to approximately $318,000.
Several other institutional investors have also adjusted their positions in National Health Investors recently. Notably, Bank of New York Mellon Corp raised its holdings by 5.6% in Q1, acquiring an additional 31,451 shares, bringing its total ownership to 588,871 shares valued at around $43.5 million. Centersquare Investment Management LLC expanded its stake by 25.7%, now owning 495,971 shares worth $36.6 million after an additional purchase of 101,538 shares.
Other significant investors include UBS Asset Management, which increased its holdings by 9.6% in the first quarter, and Sound Income Strategies LLC, which grew its position by 8.3% in Q2. MetLife Investment Management LLC made an impressive move, increasing its stake by 706.6%, now holding 213,730 shares valued at $15.8 million. Currently, institutional investors and hedge funds own approximately 62.51% of National Health Investors’ stock.
Stock Performance and Dividends
As of the latest trading session, National Health Investors’ stock opened at $74.77. Over the past year, shares have fluctuated between a low of $65.13 and a high of $82.32. The company boasts a market capitalization of $3.55 billion and has a price-to-earnings (P/E) ratio of 23.89. Recent financial metrics indicate a debt-to-equity ratio of 0.75 and a current ratio of 10.91.
On October 31, 2023, National Health Investors paid a quarterly dividend of $0.92 per share, an increase from its previous dividend of $0.90. This dividend represents an annualized total of $3.68 and yields approximately 4.9%. The dividend payout ratio stands at 117.57%, signaling a commitment to returning value to shareholders.
Analyst Ratings and Future Outlook
National Health Investors has attracted attention from analysts, with various price targets being set. National Bankshares recommended a price target of $90.00 in a report on October 1, while Truist Financial raised its target from $77.00 to $81.00, maintaining a “buy” rating. Wells Fargo & Company also increased its price target to $80.00 with an “equal weight” rating.
Analysts have generally expressed positive views on the stock. According to MarketBeat data, the consensus rating for National Health Investors is “Buy,” with an average target price of $84.83. One analyst has rated it as a Strong Buy, while four others have given it a Buy rating, and one has assigned a Hold rating.
Incorporated in 1991, National Health Investors, Inc. specializes in real estate investment related to senior housing and medical facilities. Its portfolio includes independent living, assisted living, memory care communities, and skilled nursing facilities, positioning it as a key player in the healthcare real estate market.
For comprehensive insights into National Health Investors and recent market activities, stakeholders can consult various financial news platforms and market analysis reports.
